News Briefs

Israeli company Aporia says its artificial intelligence control tool Guardrails has been selected as one of TIME’s 2024 Best Inventions, a list of 200 pioneering innovations redefining the way we live.  

Guardrails, which mitigates evolving risks in AI systems real-time, has been recognized as one of the 10 companies in the AI technology category. 

The list was created following a thorough process in which TIME’s global editors and correspondents assessed each candidate based on several critical factors, such as originality, efficacy, ambition, and impact.

“We’re incredibly proud to see Aporia’s Guardrails recognized by TIME as one of the year’s best inventions,” said Aporia CEO Liran Hason. 

“Aporia is committed to making AI applications safer and more reliable for everyone—from businesses to everyday consumers,” he said. 

We’re developing rigorous Guardrail policies, implementing advanced capabilities to ensure compliance with AI regulations in the EU and US, expanding capabilities to secure a broader range of AI systems, and welcoming new customers. Our Guardrails do more than manage glitches; they empower companies to deploy AI that users can trust.”

The company has also been named a Technology Pioneer by the World Economic Forum, and recently announced partnerships with Google Cloud and Microsoft. 

[sharethis-inline-buttons]

Medical researchers at Tel Aviv University (TAU) have discovered a way to help the body fight cancerous tumors that are even resistant to prevailing forms of immunotherapy.

The researchers found that reversing a mechanism preventing the immune system from attacking tumors can stimulate the immune system to fight the cancer cells. 

The breakthrough was led by Prof. Carmit Levy, Prof. Yaron Carmi, and PhD student Avishai Maliah from TAU’s Faculty of Medical & Health Sciences. The paper was published in the leading journal Nature Communications.

Levy said the discovery occurred at his lab, which studies both cancer and the effects of ultraviolet (UV) radiation from the sun on our skin and body  – both of which are known to suppress the immune system. 

“Cancer suppresses approaching immune cells and solar radiation suppresses the skin’s immune system,” he explained. 

“While in most cases, we cancer researchers worldwide focus on the tumor and look for mechanisms by which cancer inhibits the immune system, here we proposed a different approach: investigating how UV exposure suppresses the immune system and applying our findings to cancer. The discovery of a mechanism that inhibits the immune system opens new paths for innovative therapies.”

The research was recently published in the leading journal Nature Communications.

[sharethis-inline-buttons]

The tech incubator operated by Ashdod Port is investing $2 million in three startups as part of its strategy to foster innovation at the site. 

The sum was approved by the port’s board of directors as part of its Corporate Venture Capital (CVC) investment fund, subject to the approval of the Government Companies Authority. 

Since its establishment in 2021, the incubator has supported more than 90 startups in various fields, including operations, logistics, cyber and safety. 

The three startups were selected following a pilot program lasting an average of six months, during which the technologies being developed were tested in close cooperation with the port’s staff. 

The three startups are:

Makalu Optics, which develops groundbreaking LiDAR technology for various applications  

Treedis, which develops an advanced digitally compatible solution based on virtual and augmented reality  

Flyz Robotics, which developed an autonomous system for miniature drone robots with unique capabilities  

“The Ashdod Port Company views investments in technology companies as a strategic move, which will help us meet both the challenges of the current period of time and the global challenges faced by ports all over the world and, in parallel, optimize our competitive ability,” said Shaul Schneider, the chairman Ashdod Port Board of Directors. 

“We are confident that this investment will yield optimal results for the Port of Ashdod, for the Israeli economy, as well as for the international port industry.”

[sharethis-inline-buttons]

With conspiracy theories and so-called fake news rampant on social media, in particular during major election periods, researchers at Ben-Gurion University of the Negev (BGU) have developed a method to help fact checkers keep up with increasing volumes of misinformation on these platforms.

A team led by Dr. Nir Grinberg and Prof. Rami Puzis of BGU’s Department of Software and Information Systems Engineering found that tracking fake news sources, rather than individual articles or posts, can significantly lower the burden on fact checkers and produce reliable results over time.

The researchers’ audience-based models outperformed the more common approach of looking at who’s sharing misinformation by large margins: 33 percent when looking at historical data, and 69 percent when looking at sources as they emerge over time.

The authors also showed that their approach can maintain the same level of accuracy in identifying fake news sources while requiring less than a quarter of the fact-checking costs.

“The problem today with the proliferation of fake news is that fact checkers are overwhelmed,” explained Grinberg. 

“They cannot fact check everything … [and] we know little about how successful fact checkers are in getting to the most important content to fact check. That prompted us to develop a machine learning approach that can help fact checkers direct their attention better and boost their productivity,” he said.  
The team’s findings were published recently in Proceedings of the 30th ACM SIGKDD Conference on Knowledge Discovery and Data Mining.

[sharethis-inline-buttons]

Israeli military technology company Elbit Systems has announced that it has been awarded an approximately $200 million contract by the nation’s Ministry of Defense to supply high-power laser systems for the Iron Beam air defense platform.

The mobile Iron Beam system consists of two pivoting laser guns, a surveillance system to track the incoming projectile and a control center staffed by personnel who issue commands to the system. 

The laser gun creates a high-energy beam that can bring down missiles, mortars and drones at a reported maximum range of 10 km. The laser heats its target to incredibly high temperatures very quickly, rendering it obsolete. 

According to the contract, Elbit will supply the ministry with its proprietary high-power laser solution in order to provide a robust defense against a variety of threats. The contract also includes the provision of ongoing support services.

“As Israel’s Laser Center and a global leader in high-power laser technology, Elbit Systems congratulates on the significant progress made in the Iron Beam project and is proud of its contribution to its success. The capabilities developed at Elbit Systems represent a leap forward in future defense against various threats,” said Bezhalel (Butzi) Machlis, the president and CEO of Elbit Systems. 

The Haifa-based company, which has almost 20,000 personnel working across five continents, says its products allow its clients around the world “to address rapidly evolving battlefield challenges and overcome threats.”

[sharethis-inline-buttons]

Researchers at Tel Aviv University have found that the Oriental hornet is the only known animal in nature capable of consuming alcohol chronically and in high concentrations with almost no negative effects on their health or lifespan. 

The researchers hope that the discovery could help future studies into alcoholism and how alcohol metabolizes in our bodies. 

The research was conducted under the leadership of postdoctoral fellow Dr. Sofia Bouchebti from the laboratory of Prof. Eran Levin at Tel Aviv University’s School of Zoology and the Steinhardt Museum of Natural History. 

The team tested the Oriental hornet’s ability to consume and break down alcohol, and were surprised by the rapid rate at which the insects metabolized it. 

They also found that even high concentrations of alcohol had no noticeable effect on the hornets’ behavior and that there was no difference in lifespan for hornets that only consumed alcohol for their entire three-month lives and those that consumed sugar water.

“This is a remarkable animal that shows no signs of intoxication or illness even after ingesting huge amounts of alcohol,” said the research team. 

“While alcohol-related research is highly advanced, with 5.3 percent of deaths in the world linked to alcohol consumption, we believe that, following our research, Oriental hornets could potentially be used to develop new models for studying alcoholism and the metabolism of alcohol,” said Prof. Levin. 

The study was published in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

[sharethis-inline-buttons]

Israeli company Dataloop AI has announced a collaboration with American multinational Qualcomm Technologies, which aims to significantly accelerate AI model development for mobile, automotive, IoT and other computing devices powered by Snapdragon platforms.

Snapdragon is a versatile suite of system-on-chip (SoC) semiconductor products for a range of devices designed and marketed by Qualcomm, including mobile devices, tablets and laptops.

Dataloop enables developers to streamline the entire AI lifecycle through an automated pipeline that includes data curation, labeling, model fine-tuning, and integration with Qualcomm AI Hub, which compiles, optimizes, and profiles the ready-to-deploy model.

“The Qualcomm AI Hub helps enhance the efficiency of AI development. Dataloop’s comprehensive platform simplifies the entire AI lifecycle, while Qualcomm Technologies’ innovations enable models that are optimized and ready for deployment on edge devices, empowering developers to accelerate innovation and bring AI solutions to market faster,” said Dataloop AI co-founder and CBO Nir Buschi.

“Qualcomm Technologies is collaborating with Dataloop to streamline on-device AI deployment,” said Siddhika Nevrekar, senior director of product management at Qualcomm.

“With Dataloop’s automated pipelines and robust data management, developers can effortlessly create powerful AI systems and seamlessly deploy them on-device using our Qualcomm AI Hub.”

[sharethis-inline-buttons]

Leading green power company Enlight Renewable Energy has announced the completion of its Solar and Storage Cluster project in Israel, covering 12 locations in the north and the south of the country. 

The 12 installations were built in cooperation with multiple agricultural communities in Israel, and have a combined solar generation capacity of 254 MW and energy storage capacity of 594 MWh. While portions of it began commercial operation in 2023 and grid connections continued throughout 2024, the process has now been completed.

The Cluster’s entire output will be sold to Enlight’s supplier division, which markets the electricity directly to customers in Israel’s newly deregulated power market. 

The generation volumes of the Cluster currently account for 50 percent of all clean power produced under the new regulatory framework. 

“Today we completed the commencement of full commercial operations at the largest group of renewable energy facilities operating in Israel’s deregulated power market,” said Enlight MENA General Manager Gilad Peled. 

“The Cluster will generate attractive returns for Enlight, while creating a stable and vital source of income for our partners in the agricultural communities of Israel.”

Enlight is headquartered in Rosh Ha’ayin and operates in multiple countries worldwide, including Italy, Spain, Sweden and the US. 

[sharethis-inline-buttons]

An Israeli company that develops cannabis-based therapeutics says its CBD injections have proven effective in providing pain relief for dogs with naturally occurring osteoarthritis. 

According to InnoCan Pharma, a long-term treatment plan consistently demonstrated the LPT-CBD injection’s efficacy in pain reduction and improved mobility, with the effects lasting for several weeks after each treatment. 

This, the company says, demonstrates that LPT-CBD can be a viable treatment option for managing chronic pain and enhancing the quality of life in animals.

Two dogs suffering from osteoarthritis were treated for two years or more with LPT-CBD after failing to respond to non-steroidal anti-inflammatory drugs and oral CBD. Both animals showed noticeable pain relief, substantially improved mobility and obvious increased well-being. 

“We are thrilled with these findings, which highlight the long-lasting effects of repeated administration of LPT-CBD to treat chronic pain,” said InnoCan CSO Prof. Chezy Barenholz. 

“These results support the potential of LPT-CBD as a monthly treatment for chronic pain conditions, providing sustained relief. They position LPT-CBD as a breakthrough solution for managing chronic pain in animals and, by extension, human patients,” he said.

“This compassionate therapy has demonstrated significant efficacy in companion dogs and reinforces our commitment to advance FDA’s Center for Veterinary Medicine (CVM) approval of LPT-CBD for the treatment of chronic pain in dogs,” said Dr. Eyal Kalo, InnoCan’s director of R&D.

[sharethis-inline-buttons]

The US government is funding the development of an effective treatment created by Israeli firm RedHill Biopharma for the rare and deadly Ebola virus (EBOV).

The funding comes via the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services’ Administration for Strategic Preparedness and Response (ASPR).  

A study last year carried out by RedHill found that twice-daily oral doses of its opaganib medication boosted survival from about six days to 11 days in mice infected with Ebola. 

Opaganib is a host-directed therapy, meaning rather than destroying the pathogen directly, it makes its local environment less favorable to grow and live in. 

The drug is also in development as a treatment for multiple cancers, COVID-19 and viral and inflammatory diseases.  

“EBOV is deadly, killing, on average, half of all those who contract it. This year marks 10 years since the West Africa Ebola epidemic in which 11,000 people died, and yet there are still no host-directed, small molecule therapies approved to provide effective and usable treatment strategies,” said RedHill Chief Business Officer Guy Goldberg.  

 “Currently only Inmazeb, a combination of three monoclonal antibodies, and Ebanga, a single monoclonal antibody, are FDA-approved to treat EBOV, as such there is an urgent medical need for additional effective and easy to distribute and administer EBOV therapies,” he said.  

[sharethis-inline-buttons]

Israeli company SuperCom, which provides security solutions for digital operations, has been awarded a five-year contract by the government-run Israel Prison Service (IPS) to deploy its PureSecurity Electronic Monitoring (EM) Suite, alongside its prime partner Electra. 

The full-service contract, which is already in effect, includes all EM programs within Israel, including SuperCom’s existing Home Detention Monitoring program and additional GPS Tracking programs.

The program is expected to cover all EM offender programs in Israel, with an estimated 1,500 enrollees and potential for expansion. SuperCom says it will deploy its cutting-edge EM solutions, including PureCom, PureTrack, PureTag, and PureBeacon. 

The contract also includes the option for up to four one-year extensions.  

“We are deeply honored to support Israel’s public safety infrastructure during these challenging times,” said SuperCom CEO and President Ordan Trabelsi. 

“By providing the Israel Prison Service state agency with our advanced electronic monitoring solutions, we reaffirm our unwavering commitment to making Israel safer for all its citizens,” he said.

“We also thank our partner, Electra, one of the most reputable and reliable nationwide security services providers. Together, we offered a winning proposal that combines the most advanced technologies and services to meet the critical needs of the IPS.”  

[sharethis-inline-buttons]

CivicLabs, a joint initiative by the Israeli government and private industry to help the high-tech industry in the north, has launched a new program designed to promote startups in the Built Environment (human-created spaces) sector. 

The initiative was devised by Baran Group, Israel’s largest engineering company, and the program focuses on early-stage startups in the sector that have demonstrated both technological and business feasibility.

Forty percent of the startups participating in the program are from the north of Israel, where swathes of the area have been devastated by rocket fire from the Hezbollah terrorist group in Lebanon since the day after the massive terror attack by Hamas in the south last October.

Over a period of six to eight months, the program will offer professional guidance, access to funding and investment opportunities, support for technological and business development, access to R&D infrastructure, pilot opportunities with potential customers and networking with global investors specializing in the Built Environment. 

The five startups selected for the program so far last week presented their ventures at an event held at Meta’s offices, attended by Alon Stopel, the chairman of the Israel Innovation Authority and chief scientist at the Ministry of Innovation, Science and Technology, along with investors, potential partners and leading industry experts.

“Our vision is not only to provide technological and business support but also to establish a comprehensive connection to the entire ecosystem in the north,” said CivicLabs CEO Yogev Katzir.

“This is crucial during normal times and even more so now. We believe that in this challenging period, breakthrough solutions can emerge that will transform the industry and revitalize the economy in the north. Our goal is to position Israel, particularly the north, as a leading technology hub in the Built Environment sector, thereby developing innovative technologies and strengthening the local economy,” he said. 

“The North needs support now more than ever, and at this moment, we are proud to spearhead a significant change in the industry,” said Baran Israel CEO Zohar Nevo.

“The Startup Nation, which has already demonstrated its leadership in various technological fields, is taking another step toward fostering innovation in the Built Environment sectors, which are essential for the ecosystem, independence, and resilience of the Israeli economy, now more than ever.”

[sharethis-inline-buttons]

Israel Aerospace Industries, a world leader in the aerospace and defense sectors, has opened its first American innovation center in Washington, D.C., marking the event with the launch of a new accelerator program. 

The new IAI Catalyst program focuses on a number of fields critical to the future of aerospace innovation, among them AI, quantum science, energy and space technology, with the stated aim of becoming an epicenter for aerospace innovation. 

IAI says the Catalyst program will host two cohorts every year, each comprising four startups who have passed a rigorous screening process. 

The selected startups will be provided with office space, technological and business support from IAI and an investment of $100,000, and will be encouraged to work with IAI engineers on future advanced technologies.

“We are proud to launch the Israel Aerospace Industries Innovation Center in the United States, marking a significant milestone that underscores the deep bond between Israel and the US,,” said Amir Peretz, IAI’s Chairman of the Board of Directors and former Israeli defense minister. 

“This center symbolizes the partnership between Israel and America, and the achievements that are reshaping global defense and technology. Together, we will continue to lead, innovate, and shape the future for future generations,” he said.

[sharethis-inline-buttons]

Raanana-based startup Cympire has been selected by the Israel Defense Forces to use its cybersecurity training and assessment platform for training. 

Cympire says its military-grade platform provides hyper-realistic training environments and is designed to meet the needs of military, government, enterprise organizations and higher education, 

The platform enables users to “train-as-they-fight,” offering mission-critical readiness, as well as online training content and services.

“We are honored to be selected by the IDF for this critical project. Cympire’s platform offers the most advanced capabilities for building cyber defense skills, and we are committed to supporting the IDF in maintaining their leading edge in cybersecurity,” said Cympire CEO Yaniv Shachar.

According to Cympire’s senior advisor US Maj. Gen. Neil S. Hersey, the former Deputy Commanding General – Operations at the US Army Cyber Command, the partnership underscores the company’s ability to meet the demands of elite military cyber units. 

“By leveraging Cympire’s platform, the IDF will enhance its ability to counter advanced cyber threats effectively. I am excited to see this technology being utilized in one of the world’s most challenging and dynamic cyber defense environments,” he said.

[sharethis-inline-buttons]

American pharmaceutical giant Johnson & Johnson has completed its purchase of Israeli medtech company V-Wave, which makes a device to treat heart failure, after the prospective acquisition was announced in August. 

The Israeli company has now become part of Johnson & Johnson MedTech.  

V-Wave’s proprietary, minimally invasive Ventura Interatrial Shunt (IAS) is designed to treat patients with heart failure. The shunt between the left and right atria in the heart aims to reduce elevated pressure in the left atrium. 

It received FDA Breakthrough Device Designation in 2019 and CE mark in 2020, and, according to Johnson & Johnson, has the potential to be the first device of its kind to market.

The American multinational said in August that it would pay up to $1.7 billion for V-Wave. This included a sum of $600 million upfront, followed by further payments totalling some $1.1 billion should V-Wave hit certain regulatory and commercial milestones. 

“We’re excited to officially welcome V-Wave to Johnson & Johnson MedTech,” saif Johnson & Johnson Executive VP and Worldwide Chairman Tim Schmid. 

“V-Wave’s novel implantable device, the Ventura Interatrial Shunt, offers tremendous promise for patients experiencing heart failure with reduced ejection fraction. This technology has the potential to be the first device of its kind to market. We look forward to working with the talented V-Wave team to bring this transformative innovation to patients.”

[sharethis-inline-buttons]